Telomeres, Telomerase, and Telomerase Inhibition: Clinical Implications for Cancer

Telomeres are located at the ends of eukaryotic chromosomes. The enzyme telomerase synthesized them, and they are responsible for maintaining the lengths of chromosomes. Absence of telomerase is associated with telomere shortening and aging of somatic cells, but high telomerase activity is observed in over 90% of human cancer cells. Although the disappearance of telomerase with aging is considered a natural defense against development of cancer, it is not known what triggers the reappearance of telomerase in cancer cells. Telomerase activity is directly correlated with the expression of its active catalytic component, the human telomerase reverse transcriptase (hTERT), which is controlled primarily at the level of transcription.

[1]  S. Kaye,et al.  Is small cell lung cancer the perfect target for anti-telomerase treatment? , 1999, Carcinogenesis.

[2]  Jun-Ping Liu.  Studies of the molecular mechanisms in the regulation of telomerase activity , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  G. Landberg,et al.  Telomerase activity in relation to p53 status and clinico‐pathological parameters in breast cancer , 1998, International journal of cancer.

[4]  R. DePinho,et al.  Unlimited Mileage from Telomerase? , 1999, Science.

[5]  X. Wang,et al.  Human hepatoma cell telomerase activity inhibition and cell cycle modulation by its RNA component antisense oligodeoxyribonucleotides. , 2000, Acta pharmacologica Sinica.

[6]  J. Shay,et al.  Telomerase activity as a marker of breast carcinoma in fine‐needle aspirated samples , 2000, Cancer.

[7]  P. Picci,et al.  Presence of telomerase activity in different musculoskeletal tumor histotypes and correlation with aggressiveness , 2001, International journal of cancer.

[8]  V. Ferrans,et al.  Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas. , 2001, Human pathology.

[9]  R. Weinberg,et al.  hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization , 1997, Cell.

[10]  R. W. Gracy,et al.  Impaired glycolysis of human lymphocytes during aging , 1981, Mechanisms of Ageing and Development.

[11]  Robert A. Weinberg,et al.  Creation of human tumour cells with defined genetic elements , 1999, Nature.

[12]  M. Fossel,et al.  Telomerase and the aging cell: implications for human health. , 1998, JAMA.

[13]  J. Steitz,et al.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. , 1992, The EMBO journal.

[14]  S. Haga,et al.  Determining the telomerase activity of exfoliated cells in intestinal lavage solution to detect colorectal carcinoma. , 1999, Anticancer research.

[15]  R. Yancik.  Epidemiology of cancer in the elderly. Current status and projections for the future. , 1997, Rays.

[16]  H. Cooke,et al.  In vivo loss of telomeric repeats with age in humans. , 1991, Mutation research.

[17]  H. Saito,et al.  Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor , 2001, Journal of cellular physiology.

[18]  K. Sugano.  [Molecular diagnosis of pancreatic cancer]. , 1997, Nihon Geka Gakkai zasshi.

[19]  Zheng,et al.  Telomerase Activation in Malignant Bone Tumors. , 1998, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

[20]  Amiela Globerson.  T lymphocytes and aging. , 1995, International archives of allergy and immunology.

[21]  R. Silverman,et al.  Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA , 1998, Oncogene.

[22]  D. Wallwiener,et al.  Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer , 1998, International journal of cancer.

[23]  K. Takeda,et al.  Detection of telomerase activity in exfoliated cancer cells obtained from bile. , 1999, International Journal of Oncology.

[24]  C. Englert,et al.  Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. , 2000, Cancer research.

[25]  M. Henriksson,et al.  Proteins of the Myc network: essential regulators of cell growth and differentiation. , 1996, Advances in cancer research.

[26]  P. Venugopal,et al.  Poor prognosis acute myelogenous leukemia: 3--biological and molecular biological changes during remission induction therapy. , 2001, Leukemia research.

[27]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[28]  J. Barrett,et al.  DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. , 1999, Cancer research.

[29]  M. Yutsudo,et al.  Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. , 1999, Cancer research.

[30]  R. Effros.  Ageing and the immune system. , 2001, Novartis Foundation symposium.

[31]  A. Sartorelli,et al.  Differentiation of immortal cells inhibits telomerase activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  L. Kèlland,et al.  Telomerase: biology and phase I trials. , 2001, The Lancet. Oncology.

[33]  Y. Hannun,et al.  Molecular Mechanisms of Ceramide-mediated Telomerase Inhibition in the A549 Human Lung Adenocarcinoma Cell Line* , 2001, The Journal of Biological Chemistry.

[34]  E. Schneider,et al.  Diseases and disorders of aging: an hypothesis. , 1986, Journal of chronic diseases.

[35]  María A Blasco,et al.  Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA , 1997, Cell.

[36]  O. Yokosuka,et al.  Quantitative evaluation of telomerase activity in small liver tumors: analysis of ultrasonography-guided liver biopsy specimens. , 1999, Journal of hepatology.

[37]  D. Murasko,et al.  T-cell function in aging: mechanisms of decline. , 1990, Annual review of gerontology & geriatrics.

[38]  T. Sasagawa,et al.  Application of telomerase assay for the screening of cervical lesions. , 1997, Cancer research.

[39]  S. Benchimol,et al.  Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase , 1999, Oncogene.

[40]  Y. Kondo,et al.  2-5A antisense telomerase RNA therapy for intracranial malignant gliomas. , 2000, Cancer research.

[41]  D. Johnston,et al.  Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[42]  W. Hahn,et al.  The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. , 1999, Immunity.

[43]  G. Mills,et al.  Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition , 1997, Oncogene.

[44]  K. Udupa,et al.  Effect of age on marrow macrophage number and function , 1995, Aging.

[45]  Y. Cong,et al.  The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. , 1999, Human molecular genetics.

[46]  M. Robinson,et al.  Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. , 1999, Genes & development.

[47]  T. Sugino,et al.  Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[48]  C. Osborne,et al.  Telomerase activity and survival of patients with node-positive breast cancer. , 1997, Journal of the National Cancer Institute.

[49]  S. Benchimol,et al.  Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span , 1998, Current Biology.

[50]  Y. Kashiki,et al.  Application of telomerase activity for screening of primary lung cancer in broncho-alveolar lavage fluid. , 1998, Oncology reports.

[51]  R. Silverman,et al.  2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells. , 2000, Gynecologic oncology.

[52]  J. Shay,et al.  Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells. , 2001, Journal of the National Cancer Institute.

[53]  K. Takeda,et al.  Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers. , 2000, Gastrointestinal endoscopy.

[54]  Y. Kubota,et al.  Elevated levels of telomerase activity in malignant pheochromocytoma , 1998, Cancer.

[55]  Eli Gilboa,et al.  Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. , 2000, Nature Medicine.

[56]  G. Lyman,et al.  Cancer in the elderly. Epidemiologic and clinical implications. , 1997, Clinics in geriatric medicine.

[57]  K. Ohama,et al.  Telomerase Activity in Body Cavity Fluid and Peritoneal Washings in Uterine and Ovarian Cancer , 1998, The Journal of international medical research.

[58]  A. Ducrest,et al.  Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. , 2001, Cancer research.

[59]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[60]  J. Shay,et al.  Telomerase inhibitors. , 2001, Trends in biotechnology.

[61]  T. Tollefsbol,et al.  Expression of intracellular biochemical defects of lymphocytes in aging: Proposal of a general aging mechanism which is not cell-specific , 1986, Experimental Gerontology.

[62]  Y. Kondo,et al.  Treatment of bladder cancer cells in vitro and in vivo with 2–5A antisense telomerase RNA , 2001, Gene Therapy.

[63]  T. Tollefsbol,et al.  Telomeres and Telomerase: Basic Science Implications for Aging , 2001, Journal of the American Geriatrics Society.

[64]  J. Lebkowski,et al.  Telomerase: A Target for Anticancer Therapy , 1999 .

[65]  J. Yim,et al.  The Wilms' Tumor 1 Tumor Suppressor Gene Represses Transcription of the Human Telomerase Reverse Transcriptase Gene* , 1999, The Journal of Biological Chemistry.

[66]  J. Shay.  Telomerase in human development and cancer , 1997, Journal of cellular physiology.

[67]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[68]  Jian-guo Ren,et al.  Hydroxyl radical‐induced apoptosis in human tumor cells is associated with telomere shortening but not telomerase inhibition and caspase activation , 2001, FEBS letters.

[69]  R. DePinho,et al.  Essential role of mouse telomerase in highly proliferative organs , 1998, Nature.

[70]  R. Hodes.  Molecular targeting of cancer: Telomeres as targets , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[71]  K. Mokbel,et al.  The association between telomerase, histopathological parameters, and KI-67 expression in breast cancer. , 1999, American journal of surgery.

[72]  J. Shay,et al.  Telomerase activity in human cancer. , 1996, Current opinion in oncology.

[73]  T. Tollefsbol,et al.  Carbohydrate metabolism in transforming lymphocytes from the aged , 1985, Journal of cellular physiology.

[74]  M. White,et al.  Absence of cancer–associated changes in human fibroblasts immortalized with telomerase , 1999, Nature Genetics.

[75]  J. Barrett,et al.  Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. , 1999, Cancer research.

[76]  T. Makinodan,et al.  Humoral immunity in aging. , 1974, Federation proceedings.

[77]  G. Hannon,et al.  Myc activates telomerase. , 1998, Genes & development.

[78]  J. Hipp,et al.  Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[79]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[80]  K. Hirata,et al.  Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion , 2001, Cancer.

[81]  W. Klapper,et al.  High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus. , 2001, Human pathology.

[82]  S. Gelmini,et al.  Telomerase in urological malignancy. , 2001, The Journal of urology.

[83]  T. Mitsudomi,et al.  Expression of human telomerase subunit genes in primary lung cancer and its clinical significance. , 2000, The Annals of thoracic surgery.

[84]  S. Gilman,et al.  Effects of aging on cell cooperation and lymphocyte responsiveness to cytokines. , 1983, Journal of immunology.

[85]  J. Shay,et al.  Telomerase activity is detected in pancreatic cancer but not in benign tumors. , 1997, Cancer research.

[86]  R. Dalla‐Favera,et al.  Direct activation of TERT transcription by c-MYC , 1999, Nature Genetics.

[87]  K. Naka,et al.  Effect of antisense human telomerase RNA transfection on the growth of human gastric cancer cell lines. , 1999, Biochemical and biophysical research communications.

[88]  L. Chin,et al.  Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation , 1999, Oncogene.

[89]  M. Yutsudo,et al.  Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). , 2000, Nucleic acids research.

[90]  S. Holt,et al.  Resistance to apoptosis in human cells conferred by telomerase function and telomere stability , 1999, Molecular carcinogenesis.

[91]  L. Giudice,et al.  Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. , 1998, Cancer research.

[92]  J. Shay,et al.  High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.